M. Boruban Et Al. , "Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.," 40th Annual Meeting of the American-Society-of-Clinical-Oncology , vol.22, Louisiana, United States Of America, 2004
Boruban, M. Et Al. 2004. Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.. 40th Annual Meeting of the American-Society-of-Clinical-Oncology , (Louisiana, United States Of America).
Boruban, M., Babaoglu, M., Sencan, O., Bozkurt, A., & Yasar, U., (2004). Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction. . 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America
Boruban, MC Et Al. "Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.," 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 2004
Boruban, MC Et Al. "Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.." 40th Annual Meeting of the American-Society-of-Clinical-Oncology , Louisiana, United States Of America, 2004
Boruban, M. Et Al. (2004) . "Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.." 40th Annual Meeting of the American-Society-of-Clinical-Oncology , Louisiana, United States Of America.
@conferencepaper{conferencepaper, author={MC Boruban Et Al. }, title={Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.}, congress name={40th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Louisiana}, country={United States Of America}, year={2004}}